Key findings from a new report by R4D's Center for Global Health R&D Policy Assessment were presented for the first time today, April 5, at the Cambridge Healthtech Institute (CHI) conference, “Encouraging Development of Therapeutics for Neglected Diseases and Collaborative Innovation in Biomedicine,” in Philadelphia, PA.
The report, the second in a series from R4D, examines the potential for open source research models, which have played a critical role in the creation of computer software and other information technologies, to advance the development of new health tools for the world’s poor, including urgently needed drugs, vaccines, diagnostics and medical devices.
The report’s authors Hassan Masum and Rachelle Harris explore whether and how open source approaches can be adapted for biomedical research, in order to speed timelines and reduce the costs of R&D, encourage more fruitful collaborations, and build a stronger shared knowledge base for future biomedical innovation.
The Center for Global Health R&D Policy Assessment's goal is to expand and improve the information used by governments, philanthropists and private investors in making decisions on new ways to accelerate global health research and development. To learn more visit http://healthresearchpolicy.org/
To download the full report click here.
